Contact Lens & Anterior Eye
Volume 31, Issue 3 , Pages 141-146 , June 2008

Oral omega-6 essential fatty acid treatment in contact lens associated dry eye

  • Karolien H. Kokke

      Affiliations

    • Contact Lens Department Sussex Eye Hospital, UK
    • ,
  • Judith A. Morris

      Affiliations

    • Henry Wellcome Laboratories for Visual Sciences, Department of Optometry and Visual Science, City University, London EC1V OHB, UK
    • ,
  • John G. Lawrenson

      Affiliations

    • Henry Wellcome Laboratories for Visual Sciences, Department of Optometry and Visual Science, City University, London EC1V OHB, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 040 4310; fax: +44 207 0408494.

References 

  1. Brennan NA, Efron N. Symptomology of HEMA contact lens wear. Optom Vis Sci. 1989;66:834–838
  2. Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci. 2000;77:40–46
  3. Young G, Veys J, Pritchard N, Coleman S. A multi-centre study of lapsed contact lens wearers. Ophth Physiol Opt. 2002;22:516–527
  4. Farris RL. The dry eye: its mechanisms and therapy, with evidence that contact lens is a cause. CLAO J. 1986;12:234–246
  5. Lowther GE. Comparison of hydrogel contact lens patients with and without the symptom of dryness. Int Contact Lens Clin. 1993;20:191–194
  6. Thai LC, Tomlinson A, Doane MG. Effect of contact lens materials on tear physiology. Optom Vis Sci. 2004;81:194–204
  7. Maruyama K, Yokoi N, Takamata A, Kinoshita S. Effect of environmental conditions on tear dynamics in soft contact lens wearers. Invest Ophthalmol Vis Sci. 2004;45:2563–2568
  8. Nichols JJ, Mitchell GL, King-Smith PE. Thinning rate of the precorneal and prelens tear films. Invest Ophthalmol Vis Sci. 2005;46:2353–2361
  9. Nichols JJ, Mitchell GL, King-Smith PE. The impact of contact lens care solutions on the thickness of the tear film and contact lens. Cornea. 2005;24:825–832
  10. Glasson MJ, Stapleton F, Keay L, Sweeney D, Willcox MD. Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers. Invest Ophthalmol Vis Sci. 2003;44:5116–5124
  11. Malet F, Karsenti D, Pouliquen P. Preservative-free ocular hydrating agents in symptomatic contact lens wearers: saline versus PVP solution. Eye Contact Lens. 2003;29:38–43
  12. Guillon M, Maissa C, Pouliquen P, Delval L. Effect of povidone 2% preservative-free eyedrops on contact lens wearers with computer visual syndrome: pilot study. Eye Contact Lens. 2004;30:34–39
  13. Riley C, Chalmers RL, Pence N. The impact of lens choice in the relief of contact lens related symptoms and ocular surface findings. Contact Lens Ant Eye. 2005;28:9–13
  14. Giovagnoli D, Graham SJ. Inferior punctal occlusion with removable silicone punctal plugs in the treatment of dry-eye related contact lens discomfort. J Am Optom Assoc. 1992;63:481–485
  15. Virtenal T, Huotari K, Harkonen M, Tervo T. Lacrimal plugs as a therapy for contact lens intolerance. Eye. 1996;10:727–731
  16. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78:409–416
  17. Smith RE. The tear film complex: pathogenesis and emerging therapies for dry eyes. Cornea. 2005;24:1–7
  18. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337–342
  19. Hom MM. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens intolerant patients. Eye Contact Lens. 2006;32:109–111
  20. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71(suppl.):S343–S348
  21. Belch JJF, Hill A. Evening primrose oil and borage oil n rheumatic conditions. Am J Clin Nutr. 2000;71(suppl.):S352–S356
  22. Zurier RB, Rosetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, et al. Gammalinolenic acid treatment of rheumatoid arthritis. A randomized, placebo controlled trial. Arthritis Rheum. 1996;39:1808–1817
  23. Barabino M, Rolando P, Camicione G, Ravera S. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003;22:97–101
  24. Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G. Systemic omega-6 essential fatty acid treatment and PGE1 tear content in Sjogren's syndrome patients. Invest Ophthalmol Vis Sci. 2005;46:4474–4479
  25. Terry RL, Schnider CM, Holden BA, Cornish R, Grant T, Sweeney D, et al. CCLRU standards for success of daily and extended wear contact lenses. Optom Vis Sci. 1993;70:234–243
  26. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophth. 1969;82:10–14
  27. Craig JP, Tomlinson A. The importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74:8–13
  28. Barnes SA, Lindborg SR, Seaman JW. Multiple imputation techniques in small sample clinical trials. Stat Med. 2006;25:233–245
  29. Thakur A, Willcox MD. Contact lens wear alters the production of certain inflammatory mediators in tears. Exp Eye Res. 2000;70:255–259
  30. Pisella PJ, Malet F, Lejeune S, Brignole F, Debbasch C, Bara J, et al. Ocular surface changes induced by contact lens wear. Cornea. 2001;20:820–825
  31. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica. 1999;213:16–19
  32. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356–1363
  33. Rolando M, Barabino S, Mingari C, Moretti S, Giuffrida S, Calabria G. Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea. 2005;24:951–954
  34. Albietz JM. Conjunctival histologic findings of dry eye and non-dry eye contact lens wearing subjects. CLAO J. 2001;27:35–40
  35. Macri A, Giuffrida S, Amico V, Iester M, Traverso CE. Effect of linoleic acid and gamma-linolenic acid on tear production, tear clearance and on the ocular surface after photorefractive keratectomy. Greafes Arch Clin Exp Ophthalmol. 2003;241:561–566
  36. Vassilopoulos D, Zurier RB, Rossetti RG, Tsokos GC. Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells. Clin Immunol Immunopathol. 1997;83:237–244
  37. Hoyng PF, Verbey N, Thong L, van Haeringen NJ. Topical prostaglandins inhibit trauma induced inflammation in the rabbit eye. Invest Ophthalmol Vis Sci. 1986;27:217–225
  38. Pholpramool C. Secretory effect of prostaglandins on the rabbit lacrimal gland in vivo. Prostaglandins Med. 1979;3:185–192
  39. Oxholm P, Mathorpe R, Prause JU, Horrobin D. Patients with primary Sjögrens syndrome treated for two months with evening primrose oil. Scand J Reumatol. 1996;15:103–108
  40. Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;437:45–46
  41. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(suppl.):S560–S569
  42. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82:887–893

PII: S1367-0484(08)00003-9

doi: 10.1016/j.clae.2007.12.001

Contact Lens & Anterior Eye
Volume 31, Issue 3 , Pages 141-146 , June 2008

Article Tools

* Image Usage & Resolution